Literature DB >> 25677492

Synthesis of disaccharide nucleosides by the O-glycosylation of natural nucleosides with thioglycoside donors.

Shin Aoki1, Taketo Fukumoto, Taiki Itoh, Masayuki Kurihara, Shigeto Saito, Shin-ya Komabiki.   

Abstract

Disaccharide nucleosides constitute an important group of naturally-occurring sugar derivatives. In this study, we report on the synthesis of disaccharide nucleosides by the direct O-glycosylation of nucleoside acceptors, such as adenosine, guanosine, thymidine, and cytidine, with glycosyl donors. Among the glycosyl donors tested, thioglycosides were found to give the corresponding disaccharide nucleosides in moderate to high chemical yields with the above nucleoside acceptors using p-toluenesulfenyl chloride (TolSCl) and silver triflate (AgOTf) as promoters. The interaction of these promoters with nucleoside acceptors was examined by (1)H NMR spectroscopic experiments.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  O-glycosylation; chemical glycosylation; disaccharide nucleosides; nucleosides; thioglycoside

Mesh:

Substances:

Year:  2015        PMID: 25677492     DOI: 10.1002/asia.201403319

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  3 in total

1.  Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides.

Authors:  Hidehisa Someya; Taiki Itoh; Mebae Kato; Shin Aoki
Journal:  J Vis Exp       Date:  2018-07-26       Impact factor: 1.355

2.  Synthesis of Disaccharide Nucleosides Utilizing the Temporary Protection of the 2',3'-cis-Diol of Ribonucleosides by a Boronic Ester.

Authors:  Hidehisa Someya; Taiki Itoh; Shin Aoki
Journal:  Molecules       Date:  2017-10-01       Impact factor: 4.411

3.  First Total Synthesis of 5'-O-α-d-Glucopyranosyl Tubercidin.

Authors:  Wenliang Ouyang; Haiyang Huang; Ruchun Yang; Haixin Ding; Qiang Xiao
Journal:  Mar Drugs       Date:  2020-07-29       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.